Sir Ganga Ram Hospital   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Delhi India (1954)

Organization Overview

First Clinical Trial
2007
NCT01187966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dr. Ashish Kumar | Dr Nitin Sethi | Rufaida Mazahir | Sir Ganga Ram Hospital | Sir Ganga Ram Hospital, New Delhi, India | Sir Ganga Ram Hospital, New Delhi, INDIA | Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi- 110060, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Fibrosis (Phase 4)

Infections (Phase 3)

Liver Cirrhosis (Phase 4)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 3)

Pyelonephritis (Phase 3)

Respiratory Aspiration (Phase 4)

Thoracic Diseases (Phase 4)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 24